Stocks Comparison
Lifeloc Technologies vs Scientific Industries: revenue, profit, margins and growth compared
Lifeloc Technologies brought in $9M of revenue in fiscal 2025, Scientific Industries $5.1M in fiscal 2025. Revenue changed by +5.7% at Lifeloc Technologies and +5.4% at Scientific Industries on the year before, so Lifeloc Technologies grew faster. Lifeloc Technologies kept -27.4% of its revenue as net profit, Scientific Industries -24.1%. Free cash flow was -$962.1K at Lifeloc Technologies and -$8.2M at Scientific Industries.
Side by side, latest fiscal year
| LCTC | SCND | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $9M | $5.1M |
| Revenue growth | +5.7% | +5.4% |
| Net income | -$2.5M | -$1.2M |
| Net margin | -27.4% | -24.1% |
| Free cash flow | -$962.1K | -$8.2M |
| Free cash flow margin | -10.7% | -162.5% |
| Earnings per share (diluted) | -$0.90 | -$0.11 |
| Cash | $746K | $955K |
| Debt | $1.1M | n/a |
| Price to earnings | n/a | n/a |
| Market value | $11.7M | $8.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #599 of 731 · Technology | #625 of 731 · Technology |
Over the years
Questions about Lifeloc Technologies and Scientific Industries
Which is bigger by revenue, Lifeloc Technologies or Scientific Industries?
Lifeloc Technologies is bigger by revenue: $9M in fiscal 2025, against $5.1M for Scientific Industries in fiscal 2025.
Which keeps more of its revenue as profit, Lifeloc Technologies or Scientific Industries?
Lifeloc Technologies had a net margin of -27.4% in fiscal 2025; Scientific Industries had -24.1% in fiscal 2025.
Which grew revenue faster, Lifeloc Technologies or Scientific Industries?
In their latest fiscal years revenue changed by +5.7% at Lifeloc Technologies and +5.4% at Scientific Industries.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.